Skip to main content
. Author manuscript; available in PMC: 2023 Jan 25.
Published in final edited form as: Ann Thorac Surg. 2020 Sep 16;111(5):1465–1471. doi: 10.1016/j.athoracsur.2020.06.120

Table 3.

Selected Short-Term Unadjusted Clinical Outcomes of Orthotopic Heart Transplant Recipients January 2005 – June 2019, Stratified by Recipient HIV Status

Variable HIV - recipient HIV + recipient p-value
  (n=29,848) (n=75)  
Length of hospital stay (days, median [IQR]) 15 (11–23) 18 (12–31) 0.006
Acute rejection episode prior to discharge 5,286 (17.7%) 29 (38.7%) <0.001
 Treated with antirejection medication 3,091 (10.4%) 20 (26.7%) <0.001
Coronary artery disease at follow up 6,824 (22.9%) 10 (13.3%) 0.068
End stage renal disease requiring dialysis 1,874 (6.3%) 4 (5.3%) 0.921
Hospitalized during follow-up 16,077 (53.9%) 35 (46.7%) 0.257
 For rejection 3,617 (12.1%) 6 (8.0%) 0.360
 For infection 7,534 (25.2%) 10 (13.3%) 0.025
IQR, interquartile range
HHS Vulnerability Disclosure